APOA5 Gene Polymorphisms and Cardiovascular Diseases Metaprediction in Global Populations

被引:13
|
作者
Lin, Yen-Chun [1 ]
Nunez, Veronica [2 ]
Johns, Robin [3 ]
Shiao, S. Pamela K. [4 ,5 ,6 ,7 ]
机构
[1] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei, Taiwan
[2] Los Angeles County Univ Southern Calif, Med Ctr, Vasc Surg, Los Angeles, CA USA
[3] Augusta Univ, Coll Nursing, Dept Physiol & Technol Nursing, Augusta, GA USA
[4] Augusta Univ, Med Coll Georgia, Nursing Res, Augusta, GA USA
[5] Augusta Univ, Med Coll Georgia, Coll Nursing, Augusta, GA USA
[6] Augusta Univ, Med Coll Georgia, Grad Sch, Augusta, GA USA
[7] Augusta Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA
关键词
apolipoprotein A5; cardiovascular disease; metaprediction; CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN A5 GENE; HIGH-DENSITY-LIPOPROTEIN; AMBIENT AIR-POLLUTION; RISK; TRIGLYCERIDES; HYPERHOMOCYSTEINEMIA; DYSLIPIDEMIA; HOMOCYSTEINE; METAANALYSIS;
D O I
10.1097/NNR.0000000000000207
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background: Apolipoprotein A5 (APOA5) 1131 is one of the most investigated gene polymorphisms in association with cardiovascular diseases (CVD) for its roles in epigenetics pathways. Objectives: The major objective of this metaprediction study was to comprehensively examine the association of polymorphism risk subtypes of APOA5 1131 gene and potential contributing factors of CVD risks in global populations. Methods: This study is a meta-analysis to determine APOA5 gene polymorphisms as risk factors for CVDs. Following the guidelines of meta-analyses, we applied big data analytics including the recursive partition tree, nonlinear association curve fit, and heat maps for data visualization-in addition to the conventional pooled analyses. Results: A total of 17,692 CVD cases and 23,566 controls from 50 study groups were included. The frequency of APOA5 1131 CC and TC polymorphisms in Asian populations (22.2%-52.6%) were higher than that in other populations, including Caucasians and Eurasians (10.0%-25.0%). The homozygous CC and heterozygous TC genotypes (both p <.0001) were associated with increased risks for CVD and were higher in many Western nations, including Canada, Spain, the Czech Republic, Hungary, Turkey, Egypt, France, and Iran. The CC genotype was associated with greater risks (RR > 2.00, p <.0001) for dyslipidemia and myocardial infarction, whereas RR > 1.00 was associated with metabolic syndrome, coronary artery disease, and stroke. Air pollution was significantly associated with APOA5 1131 CC and TC polymorphisms. Discussion: The findings of this study provided novel insight to further understand the associations among APOA5 1131 polymorphisms, air pollution, and the development of CVDs. Methylation studies are needed to examine epigenetic factors associated with APOA5 1131 polymorphisms and CVD and to suggest potential prevention strategies for CVD.
引用
收藏
页码:164 / 174
页数:11
相关论文
共 50 条
  • [41] −1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients
    Mirelle O. Sóter
    Karina B. Gomes
    Ana P. Fernandes
    Maria das G. Carvalho
    Poliana S. Pinheiro
    Adriana A. Bosco
    Daniel D. R. Silva
    Marinez O. Sousa
    Molecular Biology Reports, 2012, 39 : 7541 - 7548
  • [42] Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia
    Pisciotta, Livia
    Fresa, Raffaele
    Bellocchio, Antonella
    Guido, Virgilia
    Oliva, Claudio Priore
    Calandra, Sebastiano
    Bertolini, Stefano
    CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2194 - 2198
  • [43] Gene Transfer of Apolipoprotein A-V Improves the Hypertriglyceridemic Phenotype of apoa5 (-/-) mice
    Sharma, Vineeta
    Beckstead, Jennifer A.
    Simonsen, Jens B.
    Nelbach, Lisa
    Watson, Gordon
    Forte, Trudy M.
    Ryan, Robert O.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (03) : 474 - 480
  • [44] APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study
    Klos, KLE
    Hamon, S
    Clark, AG
    Boerwinkle, E
    Liu, K
    Sing, CF
    JOURNAL OF LIPID RESEARCH, 2005, 46 (03) : 564 - 570
  • [45] Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects
    Teresa Domínguez-Reyes
    Constanza C. Astudillo-López
    Lorenzo Salgado-Goytia
    José F. Muñoz-Valle
    Aralia B. Salgado-Bernabé
    Iris P. Guzmán-Guzmán
    Natividad Castro-Alarcón
    Ma. E. Moreno-Godínez
    Isela Parra-Rojas
    Lipids in Health and Disease, 14
  • [46] Association between APOA5 polymorphisms and susceptibility to metabolic syndrome: a systematic review and meta-analysis
    Mozafari, Sima
    Ashoori, Marziyeh
    Meybodi, Seyed Mahdi Emami
    Solhi, Roya
    Mirjalili, Seyed Reza
    Firoozabadi, Ali Dehghani
    Soltani, Sepideh
    BMC GENOMICS, 2024, 25 (01):
  • [47] Association of common polymorphisms in GCKR and APOA5 genes with levels of HDL and LDL cholesterol in a Chinese population
    Liu, X.
    Shen, Y.
    Wu, L.
    Wang, D.
    Zhang, F.
    Zhang, Y.
    Wang, X.
    Liu, L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S103 - S103
  • [48] Lack of Evidence of the Role of APOA5 3'UTR Polymorphisms in Iranian Children and Adolescents with Metabolic Syndrome
    Salehi, Samaneh
    Emadi-Baygi, Modjtaba
    Rezaei, Majdaddin
    Kelishadi, Roya
    Nikpour, Parvaneh
    DIABETES & METABOLISM JOURNAL, 2018, 42 (01) : 74 - 81
  • [49] -1131T&gt;C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients
    Soter, Mirelle O.
    Gomes, Karina B.
    Fernandes, Ana P.
    Carvalho, Maria das G.
    Pinheiro, Poliana S.
    Bosco, Adriana A.
    Silva, Daniel D. R.
    Sousa, Marinez O.
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (07) : 7541 - 7548
  • [50] Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients
    el Yaagoubi, F. Lakbakbi
    Charoute, H.
    Bakhchane, A.
    Ajjemami, M.
    Benrahma, H.
    Errouagui, A.
    Kandil, M.
    Rouba, H.
    Barakat, A.
    PATHOLOGIE BIOLOGIE, 2015, 63 (06): : 243 - 247